Repeatability and reproducibility of deep-learning-based liver volume and Couinaud segment volume measurement tool

Abstract

Purpose Volumetric and health assessment of the liver is crucial to avoid poor post-operative outcomes following liver resection surgery. No current methods allow for concurrent and accurate measurement of both Couinaud segmental volumes for future liver remnant estimation and liver health using non-invasive imaging. In this study, we demonstrate the accuracy and precision of segmental volume measurements using new medical software, Hepatica™. Methods MRI scans from 48 volunteers from three previous studies were used in this analysis. Measurements obtained from Hepatica™ were compared with OsiriX. Time required per case with each software was also compared. The performance of technicians and experienced radiologists as well as the repeatability and reproducibility were compared using Bland–Altman plots and limits of agreement. Results High levels of agreement and lower inter-operator variability for liver volume measurements were shown between Hepatica™ and existing methods for liver volumetry (mean Dice score 0.947 ± 0.010). A high consistency between technicians and experienced radiologists using the device for volumetry was shown (± 3.5% of total liver volume) as well as low inter-observer and intra-observer variability. Tight limits of agreement were shown between repeated Couinaud segment volume (+ 3.4% of whole liver), segmental liver fibroinflammation and segmental liver fat measurements in the same participant on the same scanner and between different scanners. An underestimation of whole-liver volume was observed between three non-reference scanners. Conclusion Hepatica™ produces accurate and precise whole-liver and Couinaud segment volume and liver tissue characteristic measurements. Measurements are consistent between trained technicians and experienced radiologists. Graphic abstract

Prediction of Decompensation and Death in Advanced Chronic Liver Disease Using Deep Learning Analysis of Gadoxetic Acid-Enhanced MRI

“…Thus, our findings require further validation in patients with liver disease due to other etiologic causes. Third, a threshold of ± 13% for ΔLS-VR was chosen based on the reported reproducibility range of liver volume measurements [ 20 ], which may not address the measurement error range of LS-VR. To determine a reliable threshold for ΔLS VR, the reproducibility of MRI-based LS VR measurements needs to be determined in a future study.…”

“…Following univariable analysis, multivariable analysis was performed using two models; the baseline multivariable model included baseline MRI indices (LS-SIR and LS-VR) and clinical variables alone that showed p < 0.1 at the univariable analysis, whereas the follow-up multivariable model included both follow-up MRI indices (ΔLS-SIR and ΔLS-VR) and the variables in the baseline multivariable model. The ΔLS-VR was categorized as < -13%, -13% to 13%, and > 13%, and a threshold of ± 13% was chosen based on the reported reproducibility range of MRI-based volume measurement in a previous study [ 20 ]. The optimal cutoff values for the other MRI indices were determined using the minimum Wald p value method in the Cox model [ 21 ].…”

Update on the Use of Artificial Intelligence in Hepatobiliary MR Imaging

“…Mojtahed et al reported that the DL-based segmentation technique had a high consistency to experienced radiologists and each liver segment volume (± 3.5% of the total liver volume). 35 …”

Precision medicine for liver tumours with quantitative MRI and whole genome sequencing (Precision1 trial): study protocol for observational cohort study

“…At this visit, participants will be invited for an abdominal non-contrast enhanced MRI scan. Images will be processed to generate metrics indicating the liver tissue characteristics (Liver MultiScan ) and future liver remnant volume (Hepatica) as previously described 12…”